What is IntelliPharmaCeutics International Median PS Value?
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. IntelliPharmaCeutics International's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 was $0.028. IntelliPharmaCeutics International's 10-Year median PS Ratio is 7.1429. Therefore, the Median PS Value for today is $0.20.
As of today (2024-04-25), IntelliPharmaCeutics International's share price is $0.06. IntelliPharmaCeutics International's Median PS Value is $0.20. Therefore, IntelliPharmaCeutics International's Price to Median PS Value for today is 0.30.
The historical rank and industry rank for IntelliPharmaCeutics International's Median PS Value or its related term are showing as below:
IPCIF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3 Med: 0.37 Max: 0.6
Current: 0.3
During the past 13 years, the highest Price to Median PS Value of IntelliPharmaCeutics International was 0.60. The lowest was 0.30. And the median was 0.37.
IPCIF's Price-to-Median-PS-Value is ranked better than 78.68% of 258
companies
in the Biotechnology industry
Industry Median: 0.66
vs IPCIF: 0.30
IntelliPharmaCeutics International Median PS Value Historical Data
The historical data trend for IntelliPharmaCeutics International's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
IntelliPharmaCeutics International Median PS Value Chart
Competitive Comparison of IntelliPharmaCeutics International's Median PS Value
For the Biotechnology subindustry, IntelliPharmaCeutics International's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IntelliPharmaCeutics International's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where IntelliPharmaCeutics International's Price-to-Median-PS-Value falls into.
IntelliPharmaCeutics International Median PS Value Calculation
IntelliPharmaCeutics International's Median PS Value for today is calculated as
10-Year Median PS Ratio is 7.1429.
IntelliPharmaCeutics International's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.028.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IntelliPharmaCeutics International (OTCPK:IPCIF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
IntelliPharmaCeutics International's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.06
/
0.20
=
0.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IntelliPharmaCeutics International Median PS Value Related Terms
Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.
IntelliPharmaCeutics International (IntelliPharmaCeutics International) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IPCIF has been successfully added to your 